Read the latest press releases for 4D pharma plc.

Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.

Press release archive
Publications
4D asthma publication
14 Aug 2018, 08:26
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma
Publications
Publication - microbiota as HDAC inhibitors
30 Jul 2018, 08:32
30 July 2018 -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live…
Presentations
4D Presents at IHMC 2018
27 Jun 2018, 08:35
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
MHRA and HPRA clear Blautix Phase II study
13 Jun 2018, 08:37
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
Clinical Collaboration Agreement
7 Jun 2018, 08:38
4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of…
4D to present update on MRx0518 at upcoming meeting
4 Jun 2018, 11:45
4D pharma will present at the 2nd Annual Microbiome Discovery & Development Congress which takes…
4D Presents Phase Ib Clinical Data on Blautix
4 Jun 2018, 08:44
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
4D to present data on Blautix Phase Ib study
23 May 2018, 12:11
4D pharma will present clinical data on its IBS programme at the Digestive Disease Week 2018 Meeting…
MRx0518 - Monotherapy trial approved
21 May 2018, 08:47
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
4D to participate in upcoming microbiome meeting
10 May 2018, 12:49
4D pharma will participate in the Global Engage Microbiome Futures Conference in New York on May…
Clinical Update - Blautix IND
8 May 2018, 08:49
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
Final Results
23 Apr 2018, 08:51
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live…
4D presents data on MRx0518 MoA in immuno-oncology
21 Mar 2018, 12:55
4D pharma will present data outlining key aspects of the mode of action of MRx0518 at the Microbiome…
Oncology candidate update
21 Mar 2018, 08:52
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live…
4D pharma presents data on immuno-oncology programme
12 Feb 2018, 12:56
4D pharma will present preclinical data on its immuno-oncology programme at the Cell-Weizmann…

BACK TO TOP